ryzodeg flextouch solution for injection
novo nordisk a/s - insulin degludec (70%), insulin aspart (30%) - solution for injection - 100u/ml
escitalopram tablet
jubilant generics limited - escitalopram (escitalopram oxalate) - tablet - 10mg - escitalopram (escitalopram oxalate) 10mg - selective-serotonin reuptake inhibitors
escitalopram tablet
jubilant generics limited - escitalopram (escitalopram oxalate) - tablet - 20mg - escitalopram (escitalopram oxalate) 20mg - selective-serotonin reuptake inhibitors
nordimet
nordic group b.v. - methotrexate - arthritis, psoriatic, psoriasis, arthritis, juvenile rheumatoid, arthritis, rheumatoid - antineoplastic agents, - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet a (puva), and retinoids, and severe psoriatic arthritis in adult patients.
increlex
ipsen pharma - mecasermin - laron syndrome - pituitary and hypothalamic hormones and analogues - for the long-term treatment of growth failure in children and adolescents with severe primary insulin-like-growth-factor-1 deficiency (primary igfd).severe primary igfd is defined by:height standard deviation score ≤ -3.0 and;basal insulin-like growth factor-1 (igf-1) levels below the 2.5th percentile for age and gender and;growth hormone (gh) sufficiency;exclusion of secondary forms of igf-1 deficiency, such as malnutrition, hypothyroidism, or chronic treatment with pharmacologic doses of anti-inflammatory steroids.severe primary igfd includes patients with mutations in the gh receptor (ghr), post-ghr signalling pathway, and igf-1 gene defects; they are not gh deficient, and therefore, they cannot be expected to respond adequately to exogenous gh treatment. it is recommended to confirm the diagnosis by conducting an igf-1 generation test.
orthosis, footwear, orthopaedic, shoe, ready-made
dbs australia pty ltd - 31041 - orthosis, footwear, orthopaedic, shoe, ready-made - therapeutic footwear and insoles intended to treat/compensate for structural or functional disorders of childrens' and adults feet.
yaz drospirenone 3mg / ethinylestradiol 20 micrograms (as betadex clathrate) tablet blister pack
bayer australia ltd - ethinylestradiol, quantity: 20 microgram; drospirenone, quantity: 3 mg - tablet, uncoated - excipient ingredients: magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; purified talc; microcrystalline cellulose - yaz is indicated for use as: - an oral contraceptive. - treatment of moderate acne vulgaris in women who seek oral contraception - treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms (premenstrual syndrome), see clinical trials.
petibelle ethinylestradiol 30 microgram/ drospirenone 3 mg film coated tablet blister pack
bayer australia ltd - ethinylestradiol, quantity: 0.03 mg; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: titanium dioxide; purified talc; lactose monohydrate; magnesium stearate; hypromellose; microcrystalline cellulose - indications: petibelle is indicated for use as an oral contraceptive.
yasmin ethinylestradiol 30 micrograms / drospirenone 3 mg film coated tablet blister pack
bayer australia ltd - ethinylestradiol, quantity: 0.03 mg; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: lactose monohydrate; purified talc; titanium dioxide; magnesium stearate; hypromellose; microcrystalline cellulose - indications: yasmin is indicated for use as an oral contraceptive.
yaz flex ethinylestradiol (as betadex clathrate) 20 micrograms / drospirenone 3 mg tablet dispenser pack
bayer australia ltd - drospirenone,ethinylestradiol -